| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Parabilis Medicines, Inc. Common Stock (PBLS) has 4 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. PBLS is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 123.0K | $3.18M | - | |
| Dir | 20.2K | $522.6K | - | |
| Dir | 12.5K | $323.1K | +12.5K | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Sebulsky Alan | Director | Buy | 12,500 | $20.00 | $250,000.00 | New |